166 related articles for article (PubMed ID: 85462)
1. Antenatal screening in Oxford for fetal neural tube defects.
Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
[TBL] [Abstract][Full Text] [Related]
2. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
Wald N; Cuckle H; Nanchahal K
Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum alpha-fetoprotein screening in a provincial Health District.
Woolfson J; Holt EM; Whyman AE; Mabbs DV
Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461
[TBL] [Abstract][Full Text] [Related]
5. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
[TBL] [Abstract][Full Text] [Related]
6. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
[TBL] [Abstract][Full Text] [Related]
7. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening and diagnosis of neural tube defects in England and Wales in 1985.
Cuckle HS; Wald NJ; Cuckle PM
Prenat Diagn; 1989 Jun; 9(6):393-400. PubMed ID: 2668917
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies.
Cuckle H; Wald N; Stevenson JD; May HM; Ferguson-Smith MA; Ward AM; Barbour HM; Laurence KM; Norgaard-Pedersen B
Prenat Diagn; 1990 Feb; 10(2):71-7. PubMed ID: 1692997
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
[TBL] [Abstract][Full Text] [Related]
11. Detecting neural tube defects by amniocentesis between 11 and 15 weeks' gestation.
Crandall BF; Chua C
Prenat Diagn; 1995 Apr; 15(4):339-43. PubMed ID: 7542382
[TBL] [Abstract][Full Text] [Related]
12. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland.
Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES
Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
Layde PM; von Allmen SD; Oakley GP
Am J Public Health; 1979 Jun; 69(6):566-73. PubMed ID: 87134
[TBL] [Abstract][Full Text] [Related]
14. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results.
Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP
AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects.
Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP
Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055
[TBL] [Abstract][Full Text] [Related]
16. Amniocentesis carried out for neural tube indications in South Wales 1973-1981: outcome of pregnancies and findings in the malformed abortuses.
Laurence KM; Dew JO; Dyer C; Downey KH
Prenat Diagn; 1983 Jul; 3(3):187-201. PubMed ID: 6194521
[TBL] [Abstract][Full Text] [Related]
17. Four years' experience of maternal alpha-fetoprotein screening and its effect on the pattern of antenatal care.
Ward RH; Fairweather DV; Whyley GA; Shirley IM; Lucas M
Prenat Diagn; 1981 Apr; 1(2):91-101. PubMed ID: 6180424
[TBL] [Abstract][Full Text] [Related]
18. The impact of screening for open neural tube defects in England and Wales.
Cuckle H; Wald N
Prenat Diagn; 1987 Feb; 7(2):91-9. PubMed ID: 2437555
[TBL] [Abstract][Full Text] [Related]
19. Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects.
Ghosh A; Tang MH; Tai D; Nie G; Ma HK
Prenat Diagn; 1986; 6(2):83-7. PubMed ID: 2422642
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for neural tube defects in South Africa. An assessment.
Grace HJ
S Afr Med J; 1981 Aug; 60(8):324-9. PubMed ID: 6789464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
